Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Smoyer

Pediatric Nephrology Columbus, OH Medical Doctor

NPI 1659387827 CMS profile 166316

555 S 18Th St, Columbus, OH 43205

Open in the dashboard

General payments

$160,932

98 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$31,785 paid to institutions, not to them · program year 2024

Through program year 2025, William Smoyer of Columbus, OH is reported in the CMS Open Payments database as having received $160,932 across 98 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $31,785 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatric Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $22,704 32
2024 General $100,565 38
2023 General $4,778 6
2022 General $13,162 7
2021 General $12,452 11
2019 General $7,271 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Smoyer
  • Pediatric Nephrology median
  • Middle half of Pediatric Nephrology
  • National median

In program year 2025, general payments to William Smoyer were reported at $22,704. Among 327 Pediatric Nephrology profiles paid that year, the median was $131 and the middle half received between $47 and $474.

Show as a table
Year William Smoyer Pediatric Nephrology median Middle half National median
2019 $7,271 $123 $48–$353 $163
2020 $0 $146 $24–$2,251 $114
2021 $12,452 $138 $26–$1,371 $132
2022 $13,162 $93 $25–$427 $149
2023 $4,778 $105 $30–$375 $160
2024 $100,565 $123 $40–$481 $164
2025 $22,704 $131 $47–$474 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vertex Pharmaceuticals Incorporated $57,057 17 payments
  2. Boehringer Ingelheim International GmbH $45,612 16 payments
  3. Novartis Pharmaceuticals Corporation $25,910 28 payments
  4. Otsuka Pharmaceutical Development & Commercialization, Inc. $21,826 24 payments
  5. Pfizer Inc. $7,211 2 payments
  6. Otsuka Pharmaceutical Co., Ltd. $2,625 1 payment
  7. Apellis Pharmaceuticals, Inc. $311 3 payments
  8. Aurinia Pharma U.S., Inc. $258 3 payments
  9. AstraZeneca Pharmaceuticals LP $48 1 payment
  10. Mallinckrodt Enterprises LLC $33 1 payment
  11. Other $40 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $153,110 36 payments
  2. Travel and Lodging $5,140 25 payments
  3. Food and Beverage $2,682 37 payments
Products named General payments · program years 2019–2025
  1. Fabhalta $9,366 7 payments
  2. TOLVAPTAN $4,752 1 payment
  3. LUPKYNIS $258 3 payments
  4. Empaveli $131 1 payment
  5. FARXIGA $48 1 payment
  6. ACTHAR $33 1 payment
  7. AQUADEX SMARTFLOW CONSOLE $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

98 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Nephrology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record